nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobazam—CYP2B6—Tamoxifen—pancreatic cancer	0.104	0.15	CbGbCtD
Clobazam—CYP2B6—Irinotecan—pancreatic cancer	0.0797	0.115	CbGbCtD
Clobazam—CYP2C19—Tamoxifen—pancreatic cancer	0.0659	0.0952	CbGbCtD
Clobazam—ABCB1—Tamoxifen—pancreatic cancer	0.0532	0.0768	CbGbCtD
Clobazam—ABCB1—Gemcitabine—pancreatic cancer	0.0458	0.0662	CbGbCtD
Clobazam—ABCB1—Erlotinib—pancreatic cancer	0.0452	0.0653	CbGbCtD
Clobazam—CYP2B6—Doxorubicin—pancreatic cancer	0.0435	0.0628	CbGbCtD
Clobazam—ABCB1—Irinotecan—pancreatic cancer	0.0408	0.059	CbGbCtD
Clobazam—CYP3A4—Tamoxifen—pancreatic cancer	0.0319	0.046	CbGbCtD
Clobazam—ABCB1—Docetaxel—pancreatic cancer	0.0299	0.0432	CbGbCtD
Clobazam—ABCB1—Sunitinib—pancreatic cancer	0.0298	0.043	CbGbCtD
Clobazam—CYP3A4—Erlotinib—pancreatic cancer	0.0271	0.0391	CbGbCtD
Clobazam—CYP3A4—Irinotecan—pancreatic cancer	0.0245	0.0353	CbGbCtD
Clobazam—ABCB1—Doxorubicin—pancreatic cancer	0.0223	0.0322	CbGbCtD
Clobazam—CYP3A4—Docetaxel—pancreatic cancer	0.0179	0.0259	CbGbCtD
Clobazam—CYP3A4—Sunitinib—pancreatic cancer	0.0179	0.0258	CbGbCtD
Clobazam—CYP3A4—Doxorubicin—pancreatic cancer	0.0134	0.0193	CbGbCtD
Clobazam—SLC6A11—NRF2 pathway—FGF13—pancreatic cancer	0.00361	0.0854	CbGpPWpGaD
Clobazam—SLC6A1—NRF2 pathway—FGF13—pancreatic cancer	0.00291	0.0688	CbGpPWpGaD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00158	0.0373	CbGpPWpGaD
Clobazam—CYP2C18—FOXA1 transcription factor network—TFF1—pancreatic cancer	0.00156	0.0368	CbGpPWpGaD
Clobazam—SLC6A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.00131	0.031	CbGpPWpGaD
Clobazam—SLC6A1—Monoamine Transport—TSC2—pancreatic cancer	0.00128	0.0303	CbGpPWpGaD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00127	0.0301	CbGpPWpGaD
Clobazam—SLC6A11—Amino acid and derivative metabolism—ARG2—pancreatic cancer	0.00118	0.0278	CbGpPWpGaD
Clobazam—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.00106	0.025	CbGpPWpGaD
Clobazam—SLC6A11—NRF2 pathway—NFE2L2—pancreatic cancer	0.00101	0.0239	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000984	0.0232	CbGpPWpGaD
Clobazam—SLC6A11—NRF2 pathway—TGFA—pancreatic cancer	0.000967	0.0228	CbGpPWpGaD
Clobazam—SLC6A11—NRF2 pathway—SLC2A2—pancreatic cancer	0.000946	0.0224	CbGpPWpGaD
Clobazam—SLC6A1—NRF2 pathway—NFE2L2—pancreatic cancer	0.000817	0.0193	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000802	0.0189	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000793	0.0187	CbGpPWpGaD
Clobazam—SLC6A1—NRF2 pathway—TGFA—pancreatic cancer	0.00078	0.0184	CbGpPWpGaD
Clobazam—GABRB2—Ion channel transport—FXYD3—pancreatic cancer	0.000772	0.0182	CbGpPWpGaD
Clobazam—SLC6A1—NRF2 pathway—SLC2A2—pancreatic cancer	0.000763	0.018	CbGpPWpGaD
Clobazam—SLC6A11—NRF2 pathway—HSPA1A—pancreatic cancer	0.000728	0.0172	CbGpPWpGaD
Clobazam—CYP2C18—FOXA1 transcription factor network—SHH—pancreatic cancer	0.000716	0.0169	CbGpPWpGaD
Clobazam—GABRG2—Ion channel transport—FXYD3—pancreatic cancer	0.000706	0.0167	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000647	0.0153	CbGpPWpGaD
Clobazam—GABRA1—Ion channel transport—FXYD3—pancreatic cancer	0.000617	0.0146	CbGpPWpGaD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000597	0.0141	CbGpPWpGaD
Clobazam—SLC6A1—NRF2 pathway—HSPA1A—pancreatic cancer	0.000587	0.0139	CbGpPWpGaD
Clobazam—SLC6A1—Monoamine Transport—TNF—pancreatic cancer	0.00058	0.0137	CbGpPWpGaD
Clobazam—CYP2C18—FOXA1 transcription factor network—GCG—pancreatic cancer	0.000553	0.0131	CbGpPWpGaD
Clobazam—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000531	0.002	CcSEcCtD
Clobazam—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00053	0.002	CcSEcCtD
Clobazam—Anorexia—Irinotecan—pancreatic cancer	0.00053	0.002	CcSEcCtD
Clobazam—Infection—Fluorouracil—pancreatic cancer	0.000529	0.002	CcSEcCtD
Clobazam—Osteoarthritis—Epirubicin—pancreatic cancer	0.000528	0.00199	CcSEcCtD
Clobazam—Diplopia—Epirubicin—pancreatic cancer	0.000528	0.00199	CcSEcCtD
Clobazam—Skin disorder—Gemcitabine—pancreatic cancer	0.000526	0.00198	CcSEcCtD
Clobazam—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000524	0.00198	CcSEcCtD
Clobazam—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000522	0.00197	CcSEcCtD
Clobazam—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000522	0.00197	CcSEcCtD
Clobazam—Visual impairment—Docetaxel—pancreatic cancer	0.000522	0.00197	CcSEcCtD
Clobazam—Dizziness—Tamoxifen—pancreatic cancer	0.000521	0.00197	CcSEcCtD
Clobazam—Hypotension—Irinotecan—pancreatic cancer	0.00052	0.00196	CcSEcCtD
Clobazam—Increased appetite—Doxorubicin—pancreatic cancer	0.00052	0.00196	CcSEcCtD
Clobazam—Anorexia—Gemcitabine—pancreatic cancer	0.000516	0.00195	CcSEcCtD
Clobazam—Dizziness—Erlotinib—pancreatic cancer	0.000516	0.00195	CcSEcCtD
Clobazam—Erythema multiforme—Docetaxel—pancreatic cancer	0.000512	0.00193	CcSEcCtD
Clobazam—Anorexia—Fluorouracil—pancreatic cancer	0.000508	0.00192	CcSEcCtD
Clobazam—Hypotension—Gemcitabine—pancreatic cancer	0.000506	0.00191	CcSEcCtD
Clobazam—Eye disorder—Docetaxel—pancreatic cancer	0.000506	0.00191	CcSEcCtD
Clobazam—Insomnia—Irinotecan—pancreatic cancer	0.000503	0.0019	CcSEcCtD
Clobazam—Vomiting—Tamoxifen—pancreatic cancer	0.000501	0.00189	CcSEcCtD
Clobazam—Lethargy—Doxorubicin—pancreatic cancer	0.000498	0.00188	CcSEcCtD
Clobazam—Hypotension—Fluorouracil—pancreatic cancer	0.000498	0.00188	CcSEcCtD
Clobazam—Rash—Tamoxifen—pancreatic cancer	0.000497	0.00187	CcSEcCtD
Clobazam—Dermatitis—Tamoxifen—pancreatic cancer	0.000497	0.00187	CcSEcCtD
Clobazam—Ataxia—Epirubicin—pancreatic cancer	0.000496	0.00187	CcSEcCtD
Clobazam—Vomiting—Erlotinib—pancreatic cancer	0.000496	0.00187	CcSEcCtD
Clobazam—Somnolence—Irinotecan—pancreatic cancer	0.000494	0.00186	CcSEcCtD
Clobazam—Headache—Tamoxifen—pancreatic cancer	0.000494	0.00186	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000494	0.00186	CcSEcCtD
Clobazam—Rash—Erlotinib—pancreatic cancer	0.000492	0.00185	CcSEcCtD
Clobazam—Dermatitis—Erlotinib—pancreatic cancer	0.000491	0.00185	CcSEcCtD
Clobazam—Insomnia—Gemcitabine—pancreatic cancer	0.00049	0.00185	CcSEcCtD
Clobazam—Headache—Erlotinib—pancreatic cancer	0.000489	0.00184	CcSEcCtD
Clobazam—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000488	0.00184	CcSEcCtD
Clobazam—Diplopia—Doxorubicin—pancreatic cancer	0.000488	0.00184	CcSEcCtD
Clobazam—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000487	0.00184	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000485	0.00183	CcSEcCtD
Clobazam—Asthenia—Sunitinib—pancreatic cancer	0.000484	0.00183	CcSEcCtD
Clobazam—Decreased appetite—Irinotecan—pancreatic cancer	0.000483	0.00182	CcSEcCtD
Clobazam—Insomnia—Fluorouracil—pancreatic cancer	0.000482	0.00182	CcSEcCtD
Clobazam—Somnolence—Gemcitabine—pancreatic cancer	0.000482	0.00182	CcSEcCtD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000481	0.0114	CbGpPWpGaD
Clobazam—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00048	0.00181	CcSEcCtD
Clobazam—Fatigue—Irinotecan—pancreatic cancer	0.00048	0.00181	CcSEcCtD
Clobazam—Pruritus—Sunitinib—pancreatic cancer	0.000478	0.0018	CcSEcCtD
Clobazam—Constipation—Irinotecan—pancreatic cancer	0.000476	0.00179	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000475	0.00179	CcSEcCtD
Clobazam—Mental disorder—Docetaxel—pancreatic cancer	0.000474	0.00179	CcSEcCtD
Clobazam—Somnolence—Fluorouracil—pancreatic cancer	0.000474	0.00179	CcSEcCtD
Clobazam—Malnutrition—Docetaxel—pancreatic cancer	0.000471	0.00178	CcSEcCtD
Clobazam—Decreased appetite—Gemcitabine—pancreatic cancer	0.000471	0.00178	CcSEcCtD
Clobazam—Nausea—Tamoxifen—pancreatic cancer	0.000468	0.00177	CcSEcCtD
Clobazam—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000468	0.00176	CcSEcCtD
Clobazam—Fatigue—Gemcitabine—pancreatic cancer	0.000467	0.00176	CcSEcCtD
Clobazam—Muscular weakness—Epirubicin—pancreatic cancer	0.000465	0.00176	CcSEcCtD
Clobazam—Constipation—Gemcitabine—pancreatic cancer	0.000463	0.00175	CcSEcCtD
Clobazam—Nausea—Erlotinib—pancreatic cancer	0.000463	0.00175	CcSEcCtD
Clobazam—Decreased appetite—Fluorouracil—pancreatic cancer	0.000463	0.00175	CcSEcCtD
Clobazam—Diarrhoea—Sunitinib—pancreatic cancer	0.000462	0.00174	CcSEcCtD
Clobazam—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00046	0.00173	CcSEcCtD
Clobazam—Abdominal distension—Epirubicin—pancreatic cancer	0.000459	0.00173	CcSEcCtD
Clobazam—Ataxia—Doxorubicin—pancreatic cancer	0.000459	0.00173	CcSEcCtD
Clobazam—Feeling abnormal—Irinotecan—pancreatic cancer	0.000458	0.00173	CcSEcCtD
Clobazam—Dysphagia—Epirubicin—pancreatic cancer	0.000456	0.00172	CcSEcCtD
Clobazam—Asthma—Epirubicin—pancreatic cancer	0.000456	0.00172	CcSEcCtD
Clobazam—Muscle spasms—Docetaxel—pancreatic cancer	0.000453	0.00171	CcSEcCtD
Clobazam—Eosinophilia—Epirubicin—pancreatic cancer	0.000452	0.0017	CcSEcCtD
Clobazam—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000451	0.0017	CcSEcCtD
Clobazam—Dizziness—Sunitinib—pancreatic cancer	0.000447	0.00168	CcSEcCtD
Clobazam—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000446	0.00168	CcSEcCtD
Clobazam—Body temperature increased—Irinotecan—pancreatic cancer	0.00044	0.00166	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.00044	0.00166	CcSEcCtD
Clobazam—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000439	0.00166	CcSEcCtD
Clobazam—Bronchitis—Epirubicin—pancreatic cancer	0.000439	0.00165	CcSEcCtD
Clobazam—Anaemia—Docetaxel—pancreatic cancer	0.000435	0.00164	CcSEcCtD
Clobazam—Muscular weakness—Doxorubicin—pancreatic cancer	0.000431	0.00162	CcSEcCtD
Clobazam—Vomiting—Sunitinib—pancreatic cancer	0.000429	0.00162	CcSEcCtD
Clobazam—Body temperature increased—Gemcitabine—pancreatic cancer	0.000428	0.00162	CcSEcCtD
Clobazam—Rash—Sunitinib—pancreatic cancer	0.000426	0.00161	CcSEcCtD
Clobazam—Dermatitis—Sunitinib—pancreatic cancer	0.000425	0.0016	CcSEcCtD
Clobazam—Abdominal distension—Doxorubicin—pancreatic cancer	0.000425	0.0016	CcSEcCtD
Clobazam—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000424	0.0016	CcSEcCtD
Clobazam—Urticaria—Fluorouracil—pancreatic cancer	0.000423	0.0016	CcSEcCtD
Clobazam—Headache—Sunitinib—pancreatic cancer	0.000423	0.0016	CcSEcCtD
Clobazam—Asthma—Doxorubicin—pancreatic cancer	0.000422	0.00159	CcSEcCtD
Clobazam—Dysphagia—Doxorubicin—pancreatic cancer	0.000422	0.00159	CcSEcCtD
Clobazam—Leukopenia—Docetaxel—pancreatic cancer	0.000422	0.00159	CcSEcCtD
Clobazam—Body temperature increased—Fluorouracil—pancreatic cancer	0.000421	0.00159	CcSEcCtD
Clobazam—Eosinophilia—Doxorubicin—pancreatic cancer	0.000418	0.00158	CcSEcCtD
Clobazam—Weight increased—Epirubicin—pancreatic cancer	0.000415	0.00157	CcSEcCtD
Clobazam—Cough—Docetaxel—pancreatic cancer	0.000411	0.00155	CcSEcCtD
Clobazam—Pneumonia—Epirubicin—pancreatic cancer	0.000409	0.00154	CcSEcCtD
Clobazam—Infestation NOS—Epirubicin—pancreatic cancer	0.000407	0.00153	CcSEcCtD
Clobazam—Drowsiness—Epirubicin—pancreatic cancer	0.000407	0.00153	CcSEcCtD
Clobazam—Infestation—Epirubicin—pancreatic cancer	0.000407	0.00153	CcSEcCtD
Clobazam—Bronchitis—Doxorubicin—pancreatic cancer	0.000406	0.00153	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000403	0.00152	CcSEcCtD
Clobazam—Myalgia—Docetaxel—pancreatic cancer	0.000401	0.00151	CcSEcCtD
Clobazam—Nausea—Sunitinib—pancreatic cancer	0.000401	0.00151	CcSEcCtD
Clobazam—Asthenia—Irinotecan—pancreatic cancer	0.000399	0.00151	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000398	0.0015	CcSEcCtD
Clobazam—Urinary tract infection—Epirubicin—pancreatic cancer	0.000395	0.00149	CcSEcCtD
Clobazam—Dry mouth—Docetaxel—pancreatic cancer	0.000392	0.00148	CcSEcCtD
Clobazam—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000392	0.00148	CcSEcCtD
Clobazam—Sweating—Epirubicin—pancreatic cancer	0.00039	0.00147	CcSEcCtD
Clobazam—Asthenia—Gemcitabine—pancreatic cancer	0.000389	0.00147	CcSEcCtD
Clobazam—Confusional state—Docetaxel—pancreatic cancer	0.000388	0.00146	CcSEcCtD
Clobazam—Weight increased—Doxorubicin—pancreatic cancer	0.000384	0.00145	CcSEcCtD
Clobazam—Pruritus—Gemcitabine—pancreatic cancer	0.000383	0.00145	CcSEcCtD
Clobazam—Infection—Docetaxel—pancreatic cancer	0.000382	0.00144	CcSEcCtD
Clobazam—Diarrhoea—Irinotecan—pancreatic cancer	0.000381	0.00144	CcSEcCtD
Clobazam—Pneumonia—Doxorubicin—pancreatic cancer	0.000378	0.00143	CcSEcCtD
Clobazam—Nervous system disorder—Docetaxel—pancreatic cancer	0.000377	0.00142	CcSEcCtD
Clobazam—Pruritus—Fluorouracil—pancreatic cancer	0.000377	0.00142	CcSEcCtD
Clobazam—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000376	0.00142	CcSEcCtD
Clobazam—Infestation NOS—Doxorubicin—pancreatic cancer	0.000376	0.00142	CcSEcCtD
Clobazam—Infestation—Doxorubicin—pancreatic cancer	0.000376	0.00142	CcSEcCtD
Clobazam—Drowsiness—Doxorubicin—pancreatic cancer	0.000376	0.00142	CcSEcCtD
Clobazam—Skin disorder—Docetaxel—pancreatic cancer	0.000373	0.00141	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000373	0.00141	CcSEcCtD
Clobazam—Diarrhoea—Gemcitabine—pancreatic cancer	0.000371	0.0014	CcSEcCtD
Clobazam—Dizziness—Irinotecan—pancreatic cancer	0.000368	0.00139	CcSEcCtD
Clobazam—Anorexia—Docetaxel—pancreatic cancer	0.000366	0.00138	CcSEcCtD
Clobazam—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000366	0.00138	CcSEcCtD
Clobazam—Diarrhoea—Fluorouracil—pancreatic cancer	0.000364	0.00137	CcSEcCtD
Clobazam—Sweating—Doxorubicin—pancreatic cancer	0.000361	0.00136	CcSEcCtD
Clobazam—Hypotension—Docetaxel—pancreatic cancer	0.000359	0.00135	CcSEcCtD
Clobazam—Vomiting—Irinotecan—pancreatic cancer	0.000354	0.00133	CcSEcCtD
Clobazam—Dizziness—Fluorouracil—pancreatic cancer	0.000352	0.00133	CcSEcCtD
Clobazam—Visual impairment—Epirubicin—pancreatic cancer	0.000352	0.00133	CcSEcCtD
Clobazam—Rash—Irinotecan—pancreatic cancer	0.000351	0.00132	CcSEcCtD
Clobazam—Dermatitis—Irinotecan—pancreatic cancer	0.00035	0.00132	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00035	0.00132	CcSEcCtD
Clobazam—Headache—Irinotecan—pancreatic cancer	0.000348	0.00131	CcSEcCtD
Clobazam—Insomnia—Docetaxel—pancreatic cancer	0.000348	0.00131	CcSEcCtD
Clobazam—Erythema multiforme—Epirubicin—pancreatic cancer	0.000345	0.0013	CcSEcCtD
Clobazam—Vomiting—Gemcitabine—pancreatic cancer	0.000344	0.0013	CcSEcCtD
Clobazam—Somnolence—Docetaxel—pancreatic cancer	0.000342	0.00129	CcSEcCtD
Clobazam—Rash—Gemcitabine—pancreatic cancer	0.000342	0.00129	CcSEcCtD
Clobazam—Dermatitis—Gemcitabine—pancreatic cancer	0.000341	0.00129	CcSEcCtD
Clobazam—Eye disorder—Epirubicin—pancreatic cancer	0.000341	0.00129	CcSEcCtD
Clobazam—Headache—Gemcitabine—pancreatic cancer	0.000339	0.00128	CcSEcCtD
Clobazam—Vomiting—Fluorouracil—pancreatic cancer	0.000339	0.00128	CcSEcCtD
Clobazam—Rash—Fluorouracil—pancreatic cancer	0.000336	0.00127	CcSEcCtD
Clobazam—Dermatitis—Fluorouracil—pancreatic cancer	0.000336	0.00127	CcSEcCtD
Clobazam—Decreased appetite—Docetaxel—pancreatic cancer	0.000334	0.00126	CcSEcCtD
Clobazam—Headache—Fluorouracil—pancreatic cancer	0.000334	0.00126	CcSEcCtD
Clobazam—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000332	0.00125	CcSEcCtD
Clobazam—Fatigue—Docetaxel—pancreatic cancer	0.000331	0.00125	CcSEcCtD
Clobazam—Nausea—Irinotecan—pancreatic cancer	0.00033	0.00125	CcSEcCtD
Clobazam—Constipation—Docetaxel—pancreatic cancer	0.000329	0.00124	CcSEcCtD
Clobazam—Visual impairment—Doxorubicin—pancreatic cancer	0.000325	0.00123	CcSEcCtD
Clobazam—Nausea—Gemcitabine—pancreatic cancer	0.000322	0.00121	CcSEcCtD
Clobazam—Mental disorder—Epirubicin—pancreatic cancer	0.00032	0.00121	CcSEcCtD
Clobazam—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000319	0.0012	CcSEcCtD
Clobazam—Malnutrition—Epirubicin—pancreatic cancer	0.000318	0.0012	CcSEcCtD
Clobazam—Feeling abnormal—Docetaxel—pancreatic cancer	0.000317	0.00119	CcSEcCtD
Clobazam—Nausea—Fluorouracil—pancreatic cancer	0.000316	0.00119	CcSEcCtD
Clobazam—Eye disorder—Doxorubicin—pancreatic cancer	0.000316	0.00119	CcSEcCtD
Clobazam—Tension—Epirubicin—pancreatic cancer	0.000312	0.00118	CcSEcCtD
Clobazam—Nervousness—Epirubicin—pancreatic cancer	0.000309	0.00116	CcSEcCtD
Clobazam—Muscle spasms—Epirubicin—pancreatic cancer	0.000305	0.00115	CcSEcCtD
Clobazam—Body temperature increased—Docetaxel—pancreatic cancer	0.000304	0.00115	CcSEcCtD
Clobazam—SLC6A11—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000303	0.00716	CbGpPWpGaD
Clobazam—Vision blurred—Epirubicin—pancreatic cancer	0.000299	0.00113	CcSEcCtD
Clobazam—GABRA1—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.000298	0.00703	CbGpPWpGaD
Clobazam—Mental disorder—Doxorubicin—pancreatic cancer	0.000296	0.00112	CcSEcCtD
Clobazam—Malnutrition—Doxorubicin—pancreatic cancer	0.000294	0.00111	CcSEcCtD
Clobazam—Anaemia—Epirubicin—pancreatic cancer	0.000294	0.00111	CcSEcCtD
Clobazam—Agitation—Epirubicin—pancreatic cancer	0.000292	0.0011	CcSEcCtD
Clobazam—Tension—Doxorubicin—pancreatic cancer	0.000289	0.00109	CcSEcCtD
Clobazam—GABRA1—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.000287	0.00677	CbGpPWpGaD
Clobazam—Nervousness—Doxorubicin—pancreatic cancer	0.000286	0.00108	CcSEcCtD
Clobazam—Leukopenia—Epirubicin—pancreatic cancer	0.000284	0.00107	CcSEcCtD
Clobazam—Muscle spasms—Doxorubicin—pancreatic cancer	0.000283	0.00107	CcSEcCtD
Clobazam—Cough—Epirubicin—pancreatic cancer	0.000277	0.00105	CcSEcCtD
Clobazam—Vision blurred—Doxorubicin—pancreatic cancer	0.000277	0.00105	CcSEcCtD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	0.000276	0.00652	CbGpPWpGaD
Clobazam—Asthenia—Docetaxel—pancreatic cancer	0.000276	0.00104	CcSEcCtD
Clobazam—Pruritus—Docetaxel—pancreatic cancer	0.000272	0.00103	CcSEcCtD
Clobazam—Anaemia—Doxorubicin—pancreatic cancer	0.000272	0.00102	CcSEcCtD
Clobazam—Myalgia—Epirubicin—pancreatic cancer	0.000271	0.00102	CcSEcCtD
Clobazam—Agitation—Doxorubicin—pancreatic cancer	0.00027	0.00102	CcSEcCtD
Clobazam—Anxiety—Epirubicin—pancreatic cancer	0.00027	0.00102	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000269	0.00101	CcSEcCtD
Clobazam—GABRB2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000269	0.00634	CbGpPWpGaD
Clobazam—Dry mouth—Epirubicin—pancreatic cancer	0.000265	0.000998	CcSEcCtD
Clobazam—Leukopenia—Doxorubicin—pancreatic cancer	0.000263	0.000993	CcSEcCtD
Clobazam—Diarrhoea—Docetaxel—pancreatic cancer	0.000263	0.000992	CcSEcCtD
Clobazam—Confusional state—Epirubicin—pancreatic cancer	0.000261	0.000986	CcSEcCtD
Clobazam—Infection—Epirubicin—pancreatic cancer	0.000258	0.000972	CcSEcCtD
Clobazam—Cough—Doxorubicin—pancreatic cancer	0.000257	0.000968	CcSEcCtD
Clobazam—Nervous system disorder—Epirubicin—pancreatic cancer	0.000254	0.000959	CcSEcCtD
Clobazam—Dizziness—Docetaxel—pancreatic cancer	0.000254	0.000959	CcSEcCtD
Clobazam—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000254	0.000958	CcSEcCtD
Clobazam—Skin disorder—Epirubicin—pancreatic cancer	0.000252	0.00095	CcSEcCtD
Clobazam—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000251	0.000946	CcSEcCtD
Clobazam—Myalgia—Doxorubicin—pancreatic cancer	0.00025	0.000944	CcSEcCtD
Clobazam—Anxiety—Doxorubicin—pancreatic cancer	0.000249	0.000941	CcSEcCtD
Clobazam—SLC6A11—Metabolism—PRSS1—pancreatic cancer	0.000249	0.00588	CbGpPWpGaD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000249	0.000938	CcSEcCtD
Clobazam—Anorexia—Epirubicin—pancreatic cancer	0.000247	0.000932	CcSEcCtD
Clobazam—GABRG2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000246	0.0058	CbGpPWpGaD
Clobazam—Dry mouth—Doxorubicin—pancreatic cancer	0.000245	0.000923	CcSEcCtD
Clobazam—Vomiting—Docetaxel—pancreatic cancer	0.000244	0.000922	CcSEcCtD
Clobazam—SLC6A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000244	0.00577	CbGpPWpGaD
Clobazam—Rash—Docetaxel—pancreatic cancer	0.000242	0.000914	CcSEcCtD
Clobazam—Hypotension—Epirubicin—pancreatic cancer	0.000242	0.000914	CcSEcCtD
Clobazam—Dermatitis—Docetaxel—pancreatic cancer	0.000242	0.000913	CcSEcCtD
Clobazam—Confusional state—Doxorubicin—pancreatic cancer	0.000242	0.000913	CcSEcCtD
Clobazam—Headache—Docetaxel—pancreatic cancer	0.000241	0.000908	CcSEcCtD
Clobazam—Infection—Doxorubicin—pancreatic cancer	0.000238	0.000899	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000236	0.000891	CcSEcCtD
Clobazam—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000235	0.000888	CcSEcCtD
Clobazam—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000235	0.000886	CcSEcCtD
Clobazam—Insomnia—Epirubicin—pancreatic cancer	0.000235	0.000885	CcSEcCtD
Clobazam—Skin disorder—Doxorubicin—pancreatic cancer	0.000233	0.000879	CcSEcCtD
Clobazam—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000232	0.000875	CcSEcCtD
Clobazam—Somnolence—Epirubicin—pancreatic cancer	0.000231	0.00087	CcSEcCtD
Clobazam—SLC6A11—NRF2 pathway—TGFB1—pancreatic cancer	0.000229	0.00541	CbGpPWpGaD
Clobazam—Anorexia—Doxorubicin—pancreatic cancer	0.000229	0.000863	CcSEcCtD
Clobazam—Nausea—Docetaxel—pancreatic cancer	0.000228	0.000861	CcSEcCtD
Clobazam—GABRA1—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.000226	0.00533	CbGpPWpGaD
Clobazam—Decreased appetite—Epirubicin—pancreatic cancer	0.000225	0.00085	CcSEcCtD
Clobazam—Hypotension—Doxorubicin—pancreatic cancer	0.000224	0.000846	CcSEcCtD
Clobazam—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000224	0.000844	CcSEcCtD
Clobazam—Fatigue—Epirubicin—pancreatic cancer	0.000224	0.000843	CcSEcCtD
Clobazam—Constipation—Epirubicin—pancreatic cancer	0.000222	0.000836	CcSEcCtD
Clobazam—GABRB2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000219	0.00517	CbGpPWpGaD
Clobazam—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000219	0.000825	CcSEcCtD
Clobazam—Insomnia—Doxorubicin—pancreatic cancer	0.000217	0.000819	CcSEcCtD
Clobazam—SLC6A11—Metabolism—ARG2—pancreatic cancer	0.000216	0.0051	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000215	0.00507	CbGpPWpGaD
Clobazam—Feeling abnormal—Epirubicin—pancreatic cancer	0.000214	0.000806	CcSEcCtD
Clobazam—Somnolence—Doxorubicin—pancreatic cancer	0.000213	0.000805	CcSEcCtD
Clobazam—Decreased appetite—Doxorubicin—pancreatic cancer	0.000209	0.000787	CcSEcCtD
Clobazam—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000207	0.000781	CcSEcCtD
Clobazam—Fatigue—Doxorubicin—pancreatic cancer	0.000207	0.00078	CcSEcCtD
Clobazam—Urticaria—Epirubicin—pancreatic cancer	0.000206	0.000777	CcSEcCtD
Clobazam—Constipation—Doxorubicin—pancreatic cancer	0.000205	0.000774	CcSEcCtD
Clobazam—Body temperature increased—Epirubicin—pancreatic cancer	0.000205	0.000773	CcSEcCtD
Clobazam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—pancreatic cancer	0.000202	0.00477	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.0002	0.00473	CbGpPWpGaD
Clobazam—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000198	0.000746	CcSEcCtD
Clobazam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000192	0.00453	CbGpPWpGaD
Clobazam—Urticaria—Doxorubicin—pancreatic cancer	0.000191	0.000719	CcSEcCtD
Clobazam—Body temperature increased—Doxorubicin—pancreatic cancer	0.00019	0.000715	CcSEcCtD
Clobazam—CYP2C19—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000189	0.00446	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—TYMP—pancreatic cancer	0.000189	0.00446	CbGpPWpGaD
Clobazam—Asthenia—Epirubicin—pancreatic cancer	0.000186	0.000702	CcSEcCtD
Clobazam—SLC6A1—NRF2 pathway—TGFB1—pancreatic cancer	0.000185	0.00436	CbGpPWpGaD
Clobazam—Pruritus—Epirubicin—pancreatic cancer	0.000183	0.000692	CcSEcCtD
Clobazam—Diarrhoea—Epirubicin—pancreatic cancer	0.000177	0.000669	CcSEcCtD
Clobazam—GABRA1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000175	0.00413	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000175	0.00413	CbGpPWpGaD
Clobazam—Asthenia—Doxorubicin—pancreatic cancer	0.000172	0.000649	CcSEcCtD
Clobazam—Dizziness—Epirubicin—pancreatic cancer	0.000171	0.000647	CcSEcCtD
Clobazam—Pruritus—Doxorubicin—pancreatic cancer	0.00017	0.00064	CcSEcCtD
Clobazam—Vomiting—Epirubicin—pancreatic cancer	0.000165	0.000622	CcSEcCtD
Clobazam—Diarrhoea—Doxorubicin—pancreatic cancer	0.000164	0.000619	CcSEcCtD
Clobazam—Rash—Epirubicin—pancreatic cancer	0.000164	0.000617	CcSEcCtD
Clobazam—Dermatitis—Epirubicin—pancreatic cancer	0.000163	0.000616	CcSEcCtD
Clobazam—GABRA1—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.000163	0.00385	CbGpPWpGaD
Clobazam—Headache—Epirubicin—pancreatic cancer	0.000162	0.000613	CcSEcCtD
Clobazam—Dizziness—Doxorubicin—pancreatic cancer	0.000159	0.000598	CcSEcCtD
Clobazam—Nausea—Epirubicin—pancreatic cancer	0.000154	0.000581	CcSEcCtD
Clobazam—Vomiting—Doxorubicin—pancreatic cancer	0.000153	0.000575	CcSEcCtD
Clobazam—SLC6A11—Metabolism—GLP1R—pancreatic cancer	0.000152	0.00359	CbGpPWpGaD
Clobazam—Rash—Doxorubicin—pancreatic cancer	0.000151	0.000571	CcSEcCtD
Clobazam—Dermatitis—Doxorubicin—pancreatic cancer	0.000151	0.00057	CcSEcCtD
Clobazam—Headache—Doxorubicin—pancreatic cancer	0.00015	0.000567	CcSEcCtD
Clobazam—SLC6A11—Metabolism—DPYD—pancreatic cancer	0.00015	0.00353	CbGpPWpGaD
Clobazam—Nausea—Doxorubicin—pancreatic cancer	0.000143	0.000538	CcSEcCtD
Clobazam—SLC6A11—Metabolism—SLC2A2—pancreatic cancer	0.000142	0.00335	CbGpPWpGaD
Clobazam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000141	0.00334	CbGpPWpGaD
Clobazam—SLC6A11—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.00014	0.00331	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000127	0.003	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—AGTR1—pancreatic cancer	0.00012	0.00283	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	0.000119	0.00282	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000117	0.00276	CbGpPWpGaD
Clobazam—SLC6A1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000113	0.00267	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—CD44—pancreatic cancer	0.00011	0.0026	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000108	0.00254	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—HRAS—pancreatic cancer	0.000107	0.00254	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—GCG—pancreatic cancer	0.000105	0.00249	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	0.000102	0.00241	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—STK11—pancreatic cancer	9.91e-05	0.00234	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	9.8e-05	0.00231	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	9.78e-05	0.00231	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	8.95e-05	0.00211	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	8.78e-05	0.00207	CbGpPWpGaD
Clobazam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	8.71e-05	0.00206	CbGpPWpGaD
Clobazam—SLC6A1—Neuronal System—HRAS—pancreatic cancer	8.66e-05	0.00204	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—TYMS—pancreatic cancer	8.53e-05	0.00201	CbGpPWpGaD
Clobazam—CYP2C19—Arachidonic acid metabolism—PTGS2—pancreatic cancer	8.37e-05	0.00198	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	8.27e-05	0.00195	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	8.02e-05	0.0019	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	7.92e-05	0.00187	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	7.56e-05	0.00179	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PRSS1—pancreatic cancer	7.51e-05	0.00177	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—APOE—pancreatic cancer	6.93e-05	0.00164	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	6.93e-05	0.00164	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	6.81e-05	0.00161	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.61e-05	0.00156	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—ARG2—pancreatic cancer	6.51e-05	0.00154	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	6.35e-05	0.0015	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PIK3CG—pancreatic cancer	6.26e-05	0.00148	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	6.08e-05	0.00144	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PPARG—pancreatic cancer	6.04e-05	0.00143	CbGpPWpGaD
Clobazam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	6.01e-05	0.00142	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	5.86e-05	0.00138	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	5.83e-05	0.00138	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—TYMP—pancreatic cancer	5.69e-05	0.00134	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PIK3CD—pancreatic cancer	5.5e-05	0.0013	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	5.49e-05	0.0013	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	5.27e-05	0.00125	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	5.26e-05	0.00124	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	5.16e-05	0.00122	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	5.15e-05	0.00122	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	5.11e-05	0.00121	CbGpPWpGaD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	5.09e-05	0.0012	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	5.02e-05	0.00118	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PIK3CB—pancreatic cancer	4.79e-05	0.00113	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PTGS2—pancreatic cancer	4.75e-05	0.00112	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	4.65e-05	0.0011	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GLP1R—pancreatic cancer	4.59e-05	0.00108	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—DPYD—pancreatic cancer	4.51e-05	0.00107	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	4.46e-05	0.00105	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	4.42e-05	0.00104	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—SLC2A2—pancreatic cancer	4.28e-05	0.00101	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PTEN—pancreatic cancer	4.14e-05	0.000978	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	4.09e-05	0.000967	CbGpPWpGaD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	4.07e-05	0.00096	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.82e-05	0.000903	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—TNF—pancreatic cancer	3.82e-05	0.000903	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	3.8e-05	0.000898	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PRSS1—pancreatic cancer	3.69e-05	0.000872	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.64e-05	0.000859	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.5e-05	0.000826	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CD44—pancreatic cancer	3.32e-05	0.000783	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.32e-05	0.000783	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	3.29e-05	0.000776	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—ARG2—pancreatic cancer	3.2e-05	0.000756	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GCG—pancreatic cancer	3.18e-05	0.000751	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.06e-05	0.000722	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—STK11—pancreatic cancer	2.99e-05	0.000706	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—HRAS—pancreatic cancer	2.93e-05	0.000692	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PIK3CA—pancreatic cancer	2.92e-05	0.00069	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—TYMP—pancreatic cancer	2.8e-05	0.000661	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.79e-05	0.00066	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PRSS1—pancreatic cancer	2.79e-05	0.000659	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.72e-05	0.000643	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—HRAS—pancreatic cancer	2.68e-05	0.000633	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.59e-05	0.000613	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—TYMS—pancreatic cancer	2.57e-05	0.000607	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.53e-05	0.000596	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.5e-05	0.000591	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.44e-05	0.000576	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—ARG2—pancreatic cancer	2.42e-05	0.000571	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—AKT1—pancreatic cancer	2.39e-05	0.000564	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—ARG2—pancreatic cancer	2.36e-05	0.000558	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—HRAS—pancreatic cancer	2.34e-05	0.000553	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.26e-05	0.000534	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GLP1R—pancreatic cancer	2.26e-05	0.000533	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—DPYD—pancreatic cancer	2.22e-05	0.000524	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.2e-05	0.00052	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—TYMP—pancreatic cancer	2.11e-05	0.000499	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	2.11e-05	0.000497	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—APOE—pancreatic cancer	2.09e-05	0.000494	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—TYMP—pancreatic cancer	2.06e-05	0.000487	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.03e-05	0.000478	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.02e-05	0.000477	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.98e-05	0.000468	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PIK3CG—pancreatic cancer	1.89e-05	0.000446	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.89e-05	0.000446	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.87e-05	0.000442	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PPARG—pancreatic cancer	1.82e-05	0.00043	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.75e-05	0.000412	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.72e-05	0.000406	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.7e-05	0.000403	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.68e-05	0.000396	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.68e-05	0.000396	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.66e-05	0.000393	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.66e-05	0.000393	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PIK3CD—pancreatic cancer	1.66e-05	0.000392	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—DPYD—pancreatic cancer	1.64e-05	0.000387	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CD44—pancreatic cancer	1.63e-05	0.000385	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.59e-05	0.000376	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.57e-05	0.000372	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GCG—pancreatic cancer	1.56e-05	0.000369	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.55e-05	0.000367	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.52e-05	0.000359	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—STK11—pancreatic cancer	1.47e-05	0.000347	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.45e-05	0.000344	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PIK3CB—pancreatic cancer	1.45e-05	0.000342	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PTGS2—pancreatic cancer	1.43e-05	0.000338	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.4e-05	0.000332	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.38e-05	0.000327	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.27e-05	0.0003	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—TYMS—pancreatic cancer	1.26e-05	0.000299	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PTEN—pancreatic cancer	1.25e-05	0.000295	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CD44—pancreatic cancer	1.23e-05	0.000291	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.21e-05	0.000285	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CD44—pancreatic cancer	1.2e-05	0.000284	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.2e-05	0.000282	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GCG—pancreatic cancer	1.18e-05	0.000279	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GCG—pancreatic cancer	1.15e-05	0.000272	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—STK11—pancreatic cancer	1.11e-05	0.000262	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—STK11—pancreatic cancer	1.08e-05	0.000256	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.04e-05	0.000246	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—APOE—pancreatic cancer	1.03e-05	0.000243	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.03e-05	0.000242	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.01e-05	0.000238	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	9.57e-06	0.000226	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—TYMS—pancreatic cancer	9.56e-06	0.000226	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—TYMS—pancreatic cancer	9.33e-06	0.00022	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	9.28e-06	0.000219	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PPARG—pancreatic cancer	8.96e-06	0.000212	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PIK3CA—pancreatic cancer	8.82e-06	0.000208	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	8.16e-06	0.000193	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—APOE—pancreatic cancer	7.77e-06	0.000184	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—APOE—pancreatic cancer	7.59e-06	0.000179	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CD44—pancreatic cancer	7.41e-06	0.000175	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.36e-06	0.000174	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—AKT1—pancreatic cancer	7.2e-06	0.00017	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	7.11e-06	0.000168	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GCG—pancreatic cancer	7.11e-06	0.000168	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PTGS2—pancreatic cancer	7.05e-06	0.000166	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	7.01e-06	0.000166	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PIK3CG—pancreatic cancer	6.85e-06	0.000162	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PPARG—pancreatic cancer	6.77e-06	0.00016	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—STK11—pancreatic cancer	6.68e-06	0.000158	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PPARG—pancreatic cancer	6.61e-06	0.000156	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	6.17e-06	0.000146	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PTEN—pancreatic cancer	6.15e-06	0.000145	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PIK3CD—pancreatic cancer	6.02e-06	0.000142	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.75e-06	0.000136	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	5.37e-06	0.000127	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PTGS2—pancreatic cancer	5.33e-06	0.000126	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PIK3CB—pancreatic cancer	5.25e-06	0.000124	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PTGS2—pancreatic cancer	5.2e-06	0.000123	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—APOE—pancreatic cancer	4.67e-06	0.00011	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PTEN—pancreatic cancer	4.64e-06	0.00011	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PTEN—pancreatic cancer	4.53e-06	0.000107	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	4.34e-06	0.000102	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.22e-06	9.96e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.07e-06	9.61e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.71e-06	8.76e-05	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—AKT1—pancreatic cancer	3.54e-06	8.36e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	3.28e-06	7.74e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.23e-06	7.63e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.2e-06	7.56e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.2e-06	7.55e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.79e-06	6.6e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—AKT1—pancreatic cancer	2.68e-06	6.32e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—AKT1—pancreatic cancer	2.61e-06	6.17e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.97e-06	4.65e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.61e-06	3.8e-05	CbGpPWpGaD
